Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avalon GloboCare (ALBT) EBIT (2016 - 2025)

Avalon GloboCare's EBIT history spans 10 years, with the latest figure at -$1.8 million for Q4 2025.

  • For Q4 2025, EBIT fell 48.74% year-over-year to -$1.8 million; the TTM value through Dec 2025 reached -$7.6 million, down 56.81%, while the annual FY2025 figure was -$7.6 million, 56.81% down from the prior year.
  • EBIT reached -$1.8 million in Q4 2025 per ALBT's latest filing, down from -$76193.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $116846.0 in Q1 2023 to a low of -$10.5 million in Q4 2022.
  • Average EBIT over 5 years is -$2.6 million, with a median of -$1.9 million recorded in 2021.
  • Peak YoY movement for EBIT: soared 105.49% in 2023, then plummeted 821.52% in 2024.
  • A 5-year view of EBIT shows it stood at -$2.3 million in 2021, then tumbled by 364.12% to -$10.5 million in 2022, then rose by 6.78% to -$9.8 million in 2023, then soared by 87.5% to -$1.2 million in 2024, then plummeted by 48.74% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for ALBT's EBIT are -$1.8 million (Q4 2025), -$76193.0 (Q3 2025), and -$3.9 million (Q2 2025).